Wahlstrom Mats Insider Trades

Insider Trading History

Track insider trading activity for Wahlstrom Mats. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
MedTech Acquisition - Warrants (18/12/2025)
MedTech Acquisition - Warrants (18/12/2025) MTACW
Director
Holding Value $32.2k 147,555 shares
Last Trade
May 15, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$13.1k 60,000 shares
$0.22
$0.22
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) MTACU
Director
Holding Value $1.67M 147,555 shares
Last Trade
May 15, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$681k 60,000 shares
$11.35
$11.35
TriSalus Life Sciences
TriSalus Life Sciences TLSI
Director
Holding Value $487k 147,555 shares
Last Trade
May 15, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$152k 60,000 shares
$2.53
$3.30
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) MTACU
Director
Holding Value $3.13M 276,149 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.67M 147,032 shares
$11.35
$11.35
MedTech Acquisition - Warrants (18/12/2025)
MedTech Acquisition - Warrants (18/12/2025) MTACW
Director
Holding Value $60.2k 276,149 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32.1k 147,032 shares
$0.22
$0.22
TriSalus Life Sciences
TriSalus Life Sciences TLSI
Director
Holding Value $911k 276,149 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$371k 147,032 shares
$2.52
$3.30
Coherus Biosciences
Coherus Biosciences CHRS
Director
Holding Value $176k 112,000 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$88.5k 112,000 shares
$0.79
$1.58
MedTech Acquisition
MedTech Acquisition MTAC
Director
Holding Value $2.28M 200,945 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$170k 15,000 shares
$11.34
$11.34
MedTech Acquisition - Warrants (18/12/2025)
MedTech Acquisition - Warrants (18/12/2025) MTACW
Director
Holding Value $43.8k 200,945 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.27k 15,000 shares
$0.22
$0.22
TriSalus Life Sciences
TriSalus Life Sciences TLSI
Director
Holding Value $663k 200,945 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$82.5k 15,000 shares
$5.50
$3.30
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) MTACU
Director
Holding Value $2.28M 200,945 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$170k 15,000 shares
$11.35
$11.35
Coherus Biosciences
Coherus Biosciences CHRS
Director
Holding Value $0 0 shares
Last Trade
May 23, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$74k 99,988 shares
$0.74
$1.58
MedTech Acquisition
MedTech Acquisition MTAC
10% owner
Holding Value $1.07M 94,750 shares
Last Trade
Feb 10, 2025 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$507k 44,750 shares
$11.34
$11.34
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) MTACU
10% owner
Holding Value $1.08M 94,750 shares
Last Trade
Feb 10, 2025 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$508k 44,750 shares
$11.35
$11.35
MedTech Acquisition - Warrants (18/12/2025)
MedTech Acquisition - Warrants (18/12/2025) MTACW
10% owner
Holding Value $20.7k 94,750 shares
Last Trade
Feb 10, 2025 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$9.76k 44,750 shares
$0.22
$0.22
TriSalus Life Sciences
TriSalus Life Sciences TLSI
10% owner
Holding Value $313k 94,750 shares
Last Trade
Feb 10, 2025 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$236k 44,750 shares
$5.28
$3.30
MedTech Acquisition
MedTech Acquisition MTAC
10% owner
Holding Value $464k 40,915 shares
Last Trade
Dec 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$286k 25,188 shares
$11.34
$11.34
TriSalus Life Sciences
TriSalus Life Sciences TLSI
10% owner
Holding Value $135k 40,915 shares
Last Trade
Dec 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$100k 25,188 shares
$3.97
$3.30
MedTech Acquisition - Warrants (18/12/2025)
MedTech Acquisition - Warrants (18/12/2025) MTACW
10% owner
Holding Value $8.92k 40,915 shares
Last Trade
Dec 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.49k 25,188 shares
$0.22
$0.22
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) MTACU
10% owner
Holding Value $464k 40,915 shares
Last Trade
Dec 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$286k 25,188 shares
$11.35
$11.35

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up